Cardiology

• FDA approvals

• New devices gain FDA approval for HF

• May 6, 2013
• Medtronic today announced FDA approval and US launch of the Viva portfolio of cardiac resynchronization therapy with defibrillation devices and the Evera...More »

• Meeting News Coverage Perspective

• Waitlist mortality unchanged for sickest pediatric heart transplant patients

• May 2, 2013
• Overall waitlist mortality for children awaiting heart transplant improved from 25% in 2001 to 14% in 2011. However, the sickest children,...More »

• In the Journals

• Mitral annuloplasty device yielded suboptimal outcomes

• May 2, 2013
• A percutaneous mitral annuloplasty device was associated with a suboptimal risk–benefit ratio in patients with functional mitral regurgitation in a...More »

• Meeting News Coverage

• Prediction models may overestimate survival for PAH patients awaiting lung transplant

• May 2, 2013
• Current prediction models appear to overestimate survival for patients with pulmonary arterial hypertension who are awaiting lung transplant, according to...More »

• Trial Scorecards

• RELAX

• Cardiology Today, May 2013
• ...More »

• Meet the Board

• Uri Elkayam, MD: International expert in HF, heart disease during pregnancy

• Cardiology Today, May 2013
• Uri Elkayam, MD, has contributed decades of research in the areas of HF and heart disease in pregnancy. Through the annual Heart Failure Symposium in Los...More »

• Tolvaptan duration, usage limited due to possible liver injury

• April 30, 2013
• The FDA has determined that tolvaptan should not be used for longer than 30 days or in patients with underlying liver disease because it may cause liver...More »

• Meeting News Coverage

• Lung transplants donated after cardiac death yielded favorable outcomes

• April 30, 2013
• Survival rates of lung transplant recipients who received donations after cardiac death were favorable at 1 month and 1 year after transplant, and were...More »

• Meeting News Coverage

• Post-approval study confirms improved survival with HeartMate II LVAD

• April 29, 2013
• Use of the HeartMate II Left Ventricular Assist Device as destination therapy was associated with improved survival and reduced incidence of adverse...More »

• In the Journals

• BLOCK HF: Biventricular pacing superior to right ventricular pacing

• April 25, 2013
• Biventricular pacing was associated with improved outcomes as compared with right ventricular pacing in patients with left ventricular systolic...More »

Personalize your page!

Register for Healio to get content tailored to your specialty and areas of interest. It’s FREE and only takes one minute. Register now!